Digestive Health Institute, AdventHealth Tampa, 3000 Medical Park Drive, Suite 500, Tampa, FL, 33613, USA.
Surg Endosc. 2022 Sep;36(9):6724-6732. doi: 10.1007/s00464-021-08948-3. Epub 2022 Jan 3.
BACKGROUND: Outcome data on robotic major hepatectomy are lacking. This study was undertaken to compare robotic vs. 'open' major hepatectomy utilizing patient propensity score matching (PSM). METHODS: With institutional review board approval, we prospectively followed 183 consecutive patients who underwent robotic or 'open' major hepatectomy, defined as removal of three or more Couinaud segments. 42 patients who underwent 'open' approach were matched with 42 patients who underwent robotic approach. The criteria for PSM were age, resection type, tumor size, tumor type, and BMI. Survival was individually stratified for hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (IHCC), and colorectal liver metastases (CLM). The data are presented as: median (mean ± SD). RESULTS: Operative duration for the robotic approach was 293 (302 ± 131.5) vs. 280 (300 ± 115.6) minutes for the 'open' approach (p = NS). Estimated Blood Loss (EBL) was 200 (239 ± 183.6) vs. 300 (491 ± 577.1) ml (p = 0.01). There were zero postoperative complications with a Clavien-Dindo classification ≥ III for the robotic approach and three for the 'open' approach (p = NS). ICU length of stay (LOS) was 1 (1 ± 0) vs. 2 (3 ± 2.0) days (p = 0.0001) and overall LOS was 4 (4 ± 3.3) vs. 6 (6 ± 2.7) days (p = 0.003). In terms of long-term oncological outcomes, overall survival was similar for patients with IHCC and CLM regardless of the approach. However, patients with HCC who underwent robotic resection lived significantly longer (p = 0.05). CONCLUSION: Utilizing propensity score matched analysis, the robotic approach was associated with a lower EBL, shorter ICU LOS, and shorter overall LOS while maintaining similar operative duration and promoting survival in patients with HCC. We believe that the robotic approach is safe and efficacious and should be considered a preferred alternative approach for major hepatectomy.
背景:机器人辅助肝切除术的结果数据尚缺乏。本研究旨在利用患者倾向评分匹配(PSM)比较机器人辅助与开腹肝切除术的结果。
方法:经机构审查委员会批准,我们前瞻性地随访了 183 例连续接受机器人或开腹肝切除术的患者,肝切除术定义为切除三个或更多 Couinaud 段。42 例接受开腹手术的患者与 42 例接受机器人手术的患者相匹配。PSM 的标准为年龄、切除类型、肿瘤大小、肿瘤类型和 BMI。根据肝细胞癌(HCC)、肝内胆管细胞癌(IHCC)和结直肠癌肝转移(CLM)对生存情况进行个体化分层。数据以中位数(均数±标准差)表示。
结果:机器人组的手术时间为 293(302±131.5)分钟,开腹组为 280(300±115.6)分钟(p=NS)。估计失血量(EBL)分别为 200(239±183.6)毫升和 300(491±577.1)毫升(p=0.01)。机器人组术后无任何 Clavien-Dindo 分级≥III 级的并发症,而开腹组有 3 例(p=NS)。机器人组 ICU 住院时间(LOS)为 1(1±0)天,开腹组为 2(3±2.0)天(p=0.0001),总 LOS 分别为 4(4±3.3)天和 6(6±2.7)天(p=0.003)。在长期肿瘤学结果方面,无论采用何种方法,IHCC 和 CLM 患者的总体生存率相似。然而,接受机器人切除术的 HCC 患者的生存时间明显更长(p=0.05)。
结论:利用倾向评分匹配分析,机器人辅助手术与较低的 EBL、较短的 ICU LOS 和较短的总 LOS 相关,同时保持相似的手术时间,并促进 HCC 患者的生存。我们认为机器人手术安全有效,应被视为肝切除术的首选方法。
Surg Endosc. 2021-5
Chirurgie (Heidelb). 2025-5-9
North Clin Istanb. 2024-11-20
J Robot Surg. 2024-4-8
Ann Surg Oncol. 2020-12
J Robot Surg. 2019-4